Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 316304, 8 pages
http://dx.doi.org/10.1155/2013/316304
Research Article

Oral Immunogenicity of Plant-Made Mycobacterium tuberculosis ESAT6 and CFP10

1Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences, pr. Lavrentieva 10, Novosibirsk 630090, Russia
2State Research Center of Virology and Biotechnology Vector, Koltsovo, Novosibirsk Oblast 630559, Russia
3National Center of Biotechnology, ul. Valikhanova 13/1, Astana 010000, Kazakhstan

Received 12 June 2013; Accepted 28 November 2013

Academic Editor: Armando Acosta

Copyright © 2013 Elena A. Uvarova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [15 citations]

The following is the list of published articles that have cited the current article.

  • Marisela Hernández, Gabriela Rosas, Jacquelynne Cervantes, Gladis Fragoso, Sergio Rosales-Mendoza, and Edda Sciutto, “Transgenic plants: a 5-year update on oral antipathogen vaccine development,” Expert Review of Vaccines, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • Hui-Ting Chan, and Henry Daniell, “Plant-made oral vaccines against human infectious diseases-Are we there yet?,” Plant Biotechnology Journal, 2015. View at Publisher · View at Google Scholar
  • Sergio Rosales-Mendoza, Regina Ríos-Huerta, and Carlos Angulo, “An overview of tuberculosis plant-derived vaccines,” Expert Review of Vaccines, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Sergio Rosales-Mendoza, Carlos Angulo, and Beatriz Meza, “Food-Grade Organisms as Vaccine Biofactories and Oral Delivery Vehicles,” Trends in Biotechnology, 2015. View at Publisher · View at Google Scholar
  • Sergio Rosales-Mendoza, and Marlene Anahí Tello-Olea, “Carrot Cells: A Pioneering Platform for Biopharmaceuticals Production,” Molecular Biotechnology, 2015. View at Publisher · View at Google Scholar
  • Natalia V. Permyakova, Alla A. Zagorskaya, Pavel A. Belavin, Elena A. Uvarova, Olesya V. Nosareva, Andrey E. Nesterov, Anna A. Novikovskaya, Evgeniy L. Zav’yalov, Mikhail P. Moshkin, and Elena V. Deineko, “ Transgenic Carrot Expressing Fusion Protein Comprising M. tuberculosis Antigens Induces Immune Response in Mice ,” BioMed Research International, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Miao Xu, Xiaoyong Fan, Jun Gu, Shuihua Lu, Feng Li, Guozhi Wang, Lijun Zhou, Yanqing Xiong, Lu Xia, and Jiang Pu, “Safety of recombinant fusion protein ESAT6-CFP10 as a skin test reagent for tuberculosis diagnosis: An open-label, randomized, single-center phase i clinical trial,” Clinical and Vaccine Immunology, vol. 23, no. 9, pp. 767–773, 2016. View at Publisher · View at Google Scholar
  • Verónica A. Márquez-Escobar, Sergio Rosales-Mendoza, Josué I. Beltrán-López, and Omar González-Ortega, “Plant-based vaccines against respiratory diseases: current status and future prospects,” Expert Review of Vaccines, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Naila Shahid, and Henry Daniell, “Plant-based oral vaccines against zoonotic and non-zoonotic diseases,” Plant Biotechnology Journal, 2016. View at Publisher · View at Google Scholar
  • Mi-Young Kim, Byeong-Young Kim, and Moon-Sik Yang, “Synthesis and assembly of dengue virus envelope protein fused to cholera toxin B subunit into biologically active oligomers in transgenic tomato (Solanum lycopersicum),” Plant Biotechnology Reports, 2016. View at Publisher · View at Google Scholar
  • Matilde Merlin, Mario Pezzotti, and Linda Avesani, “Edible plants for oral delivery of biopharmaceuticals,” British Journal of Clinical Pharmacology, vol. 83, no. 1, pp. 71–81, 2016. View at Publisher · View at Google Scholar
  • Roberto Zenteno-Cuevas, “Successes and failures in human tuberculosis vaccine development,” Expert Opinion on Biological Therapy, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • F Abebe, M Belay, M Legesse, A Mihret, and K S Franken, “Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting.,” Clinical and experimental immunology, vol. 189, no. 2, pp. 241–249, 2017. View at Publisher · View at Google Scholar
  • Edoardo Bertini, Matilde Merlin, Elisa Gecchele, Andrea Puggia, Annalisa Brozzetti, Mauro Commisso, Alberto Falorni, Vittorio Bini, Victor Klymyuk, Mario Pezzotti, and Linda Avesani, “Design of a Type-1 Diabetes Vaccine Candidate Using Edible Plants Expressing a Major Autoantigen,” Frontiers in Plant Science, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Svetlana V. Bannikova, Konstantin V. Starostin, Sergey E. Peltek, Dariya S. Pirozhkova, Sergey M. Rozov, Sergey R. Mursalimov, Elena A. Uvarova, Tatiana V. Marenkova, Evgeniy A. Demidov, Marionella A. Kravchenko, Diana V. Vakhrusheva, Natalya I. Eremeeva, Pavel A. Belavin, Elena V. Deineko, Yuriy V. Sidorchuk, Natalya V. Permyakova, Roman B. Berdnikov, Sergey N. Skornyakov, Elena G. Ufimtseva, and Alla A. Zagorskaya, “The recombinant fusion protein CFP10-ESAT6-difn has protective effect against tuberculosis in Guinea pigs,” Acta Microbiologica et Immunologica Hungarica, vol. 65, no. 1, pp. 39–58, 2018. View at Publisher · View at Google Scholar